Date:June 22, 2026

Great to connect with Dr. Delese Mimi Darko, Director General of the African Medicines Agency (AMA), and Senior Advisor Prof. Alex Dodoo this week.
We commend AMA’s progress in strengthening regulatory alignment across Africa – critical as patients continue to face substandard and falsified medicines. Strong oversight is essential to protect public health.
Equally important is building a consistent supply chain of quality, affordable medicines through strengthened local manufacturing, production, and distribution of essential, locally produced products.
Bio Usawa stands ready to work alongside AMA, national regulatory authorities, and committed partners to help unlock Africa’s full biotech potential. The opportunity – and responsibility – is clear: together, we can transform access to safe, high-quality medicines.
We call on stakeholders across sectors to step forward and collaborate now to turn this vision into reality.

Partnership will advance local manufacturing of biologic medicines and expand access to innovative treatments for patients in Kenya and across Africa. …
August 2026We are pleased to see our Head of Global Regulatory Strategy, Eric Boateng-Karikari, among the authors of a newly published paper in the British Journal…
July 2026Today, Bio Usawa’s Chief Operating Officer, Dr. Patrick Lukulay, held productive discussions with Gai Nyok, Acting Political and Economic Chief at the U…
July 2026